Recent advances in CRISPR/Cas-based genome editing, including three-component 45CRISPR 1 , the use of long single-strand donors 2 , enhanced microhomology-mediated end-46 joining (MMEJ) 3 , and pharmacological approaches 4-7 have greatly improved knock-in (KI) 47 efficiency. In our search for factors to further improve KI efficiency for broad therapeutic 48 use and efficient generation of primate disease models, we found that the strand exchange 49 protein RAD51 can significantly increase homozygous KI efficiency using CRISPR/Cas9 in 50 mouse embryos through an interhomolog repair (IHR) mechanism. Using a variety of 51 approaches, we demonstrate robust enhancement of zygotic IHR by RAD51 and show that 52 this can be leveraged both for generating homozygous KI animals from wildtype zygotes 53 with exogenous donors and for converting heterozygous alleles into homozygous alleles 54 without exogenous templates. Thus, our study provides both conclusive evidence 55 supporting the existence of zygotic IHR mechanisms and a new method to significantly 56 improve IHR efficiency for potential therapeutic use. 57We previously described a three-component CRISPR approach, which employs Cas9 58 protein and chemically synthesized crRNA and tracrRNA for efficient KI of transgenes 1,2,8 . 59 Additional published work in rabbit embryos has shown significant enhancement of KI 60 efficiency using RS-1, a chemical agonist of the homology-directed repair (HDR) pathway 61 member RAD51 6 . We began our study by attempting to use a combination of these techniques 62 for high-efficiency knock-in of an autism-associated point mutation in Chd2 (c.5051G>A; 63 R1685H in human, R1684H in mouse; hereon referred to as Chd2 R1684H ; Fig. 1a) using a single-64 stranded oligonucleotide donor (ssODN). Previous studies have shown that KI efficiency is 65 affected by the proximity of the Cas9 cut site and the insertion site 9 , so we chose a guide 66 positioned where the cut site is directly adjacent to the desired G>A point mutation. Genotyping